Dirk Klingbiel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 1

Top Topics

Metastatic Breast Cancer

Stem Cell Transplantation

Locally Advanced

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Hematological oncology

Hoffmann-La Roche Ltd

University of Bern (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hoffmann-La Roche Ltd

Switzerland

Senior Biostatistician

SAKK Swiss Group for Clinical Cancer Research

Switzerland

Head of Statistics :: Statistics

SAKK Swiss Group for Clinical Cancer Research

Switzerland

Statistician :: Statistics

Education History

University of Bern - Sep 22 2009

Switzerland

PHD

Publications

Grazia Arpino, Juan R De la Haba-Rodríguez, Jean-Marc Ferrerro, Sabino De Placido, C Kent Osborne, Dirk Klingbiel, Valentine Revelant, Christine Wohlfarth, Raf Poppe, Mothaffar F Rimawi
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic/Locally Advanced Breast Cancer: PERTAIN Final Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ulrich J M Mey, Christoph Leitner, Christoph Driessen, Richard Cathomas, Dirk Klingbiel, Felicitas Hitz
Improved survival of older patients with multiple myeloma in the era of novel agents. Hematological oncology 34 (4) (2015)